Amanote Research

Amanote Research

    RegisterSign In

Biosimilars

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2018-000321
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

January 1, 2018

Authors
Miguel Martin
Publisher

BMJ


Related search

Biosimilars 2.0

mAbs
AllergyImmunology
2011English

Biosimilars in Medicine

Era's journal of medical research
2017English

Biosimilars: Approval and Acceptance?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Building a Wall Against Biosimilars

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2013English

Pcp34 - Biosimilars: What’s the Issue?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Will U.S. Payers Champion Biosimilars?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Comparative Immunogenicity Assessment of Biosimilars

Future Oncology
MedicineCancer ResearchOncology
2019English

Informationsportal Zu Biosimilars Im Internet

Best Practice Onkologie
Oncology
2011English

New Insulins, Biosimilars, and Insulin Therapy

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy